FDA Adverse Event Injury Summary report: N

ACCESS KIT 4.7

MDR report key: 6628981 · Received June 8, 2017

Report

Report Number
3000270450-2017-10189
Event Type
Injury
Date Received
June 8, 2017
Date of Event
May 17, 2017
Report Date
May 17, 2017
Manufacturer
SYNTHES SELZACH
Product Code
LXH
PMA / PMN Number
EXEMPT
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

DEVICE USED FOR TREATMENT, NOT DIAGNOSIS. PATIENT ID AND DOB NOT PROVIDED FOR REPORTING. ADDITIONAL PRODUCT CODES: FZX MJG GEA HXG HTW KIH. (B)(4) LOT UNKNOWN. DEVICE IS AN INSTRUMENT AND IS NOT IMPLANTED/EXPLANTED. DEVICE IS NOT EXPECTED TO BE RETURNED FOR MANUFACTURER REVIEW/INVESTIGATION. (B)(6). WITHOUT A LOT NUMBER, THE DEVICE HISTORY RECORD REVIEW AND THE INVESTIGATION COULD NOT BE COMPLETED; NO CONCLUSION COULD BE DRAWN, AS NO PRODUCT WAS RECEIVED. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 1

(B)(4). DEVICE USED FOR TREATMENT, NOT DIAGNOSIS. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Description of Event or Problem · 1

DEVICE REPORT FROM SYNTHES ON AN EVENT IN (B)(6) AS FOLLOWS: IT WAS REPORTED THAT DURING SPINAL FUSION ON (B)(6) 2017 THE JAMSHIDI NEEDLE PERFORATED THE AORTA. VASCULAR SURGEONS TOOK OVER THE PROCEDURE AND MANAGED THE PROBLEMS. THE SURGERY WAS PROLONGED TO AN UNKNOWN TIME. THE PATIENT WAS AFTER THE EVENT, UNSTABLE AND LATER PATIENT WAS STABLE. THIS COMPLAINT INVOLVES 1 PART. THE SURGERY WAS DELAYED AS THEY COULD NOT CONTINUE. A SECOND SURGERY IS PLANNED. THE ISSUE WAS SOLVED BY THE VASCULAR SURGEONS. THIS REPORT IS 1 OF 1 FOR (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
409617 ACCESS KIT 4.7 MISC ORTHO SURGICAL INSTRUMENT LXH SYNTHES SELZACH

Patients

Seq Age Sex Outcome Treatment
1 26 YR Required Intervention